赛马鲁肽
医学
安慰剂
耐受性
杜拉鲁肽
不利影响
内科学
临床试验
糖尿病
2型糖尿病
药理学
艾塞那肽
内分泌学
利拉鲁肽
病理
替代医学
作者
Vanita R. Aroda,Umut Erhan,Peter Jelnes,Juris J. Meier,Morten T. Abildlund,Richard E. Pratley,Tina Vilsbøll,Mansoor Husain
摘要
The most common AEs with semaglutide were gastrointestinal disorders, which decreased with continued therapy. These comprehensive safety/tolerability data may better inform patient selection and guidance in care.
科研通智能强力驱动
Strongly Powered by AbleSci AI